As shown in Table 1, PDL1 expression was generally associated with poor-prognosis features: pathological type (with more ductal and medullary carcinoma in the “PDL1-up” group), large pathological tumor size, high tumor grade, negative ER status, negative PR status, positive ERBB2 status, and positive Ki67 status. Here, CD274 is linked to neoplasm.